Advanced search
Publication Cover
Renal Failure Volume 35, 2013 - Issue 4
Submit an article Journal homepage
1,113
Views
23
CrossRef citations to date
0
Altmetric
Case Report

Tocilizumab Treatment for Nephrotic Syndrome Due to Amyloidosis in Behcet’s Disease

M.D. Redondo-PachónNephrology Section, Hospital de Elche, Elche, SpainCorrespondence[email protected]
,
R. EnríquezNephrology Section, Hospital de Elche, Elche, Spain
,
A.E. SirventNephrology Section, Hospital de Elche, Elche, Spain
,
E. AndradaPathology Section, Hospital de Elche, Elche, Spain
,
R. Noguera-PonsRheumatology Section, Hospital de Elche, Elche, Spain
,
I. MillánNephrology Section, Hospital de Elche, Elche, Spain
&
F. AmorósNephrology Section, Hospital de Elche, Elche, Spain
 show all
Pages 547-550 | Received 17 Nov 2012, Accepted 01 Feb 2013, Published online: 11 Mar 2013

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Antonio Vitale, Donato Rigante, Giuseppe Lopalco, Giacomo Emmi, Maria Teresa Bianco, Mauro Galeazzi, Florenzo Iannone & Luca Cantarini. (2016) New therapeutic solutions for Behçet’s syndrome. Expert Opinion on Investigational Drugs 25:7, pages 827-840.
Read now
Özgül Muştu Koryürek & Göknur Kalkan. (2016) A new alternative therapy in dermatology: tocilizumab. Cutaneous and Ocular Toxicology 35:2, pages 145-152.
Read now
Ina Kötter. (2015) The challenging treatment of Behcet’s disease. Expert Opinion on Orphan Drugs 3:10, pages 1101-1110.
Read now
Alice Courties, Gilles Grateau, Peggy Philippe, René-Marc Flipo, Leonardo Astudillo, Bérengère Aubry-Rozier, Isabelle Fabreguet, Wafki Fahd, Olivier Fain, Pascal Guggenbuhl, Eric Hachulla, Thomas Papo, Christophe Richez, Jean Sibilia, Jacques Morel, Francis Berenbaum & Jérémie Sellam. (2015) AA amyloidosis treated with tocilizumab: case series and updated literature review. Amyloid 22:2, pages 84-92.
Read now
Diego Real de Asúa, Ramón Costa, Jose María Galván, María Teresa Filigheddu, Davinia Trujillo & Julen Cadiñanos. (2014) Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clinical Epidemiology 6, pages 369-377.
Read now

Articles from other publishers (18)

Mohamed-Yacine Khitri, Alessandra Bartoli, Georgina Maalouf, Alban Deroux, Carlo Salvarani, Giacomo Emmi, Omer Karadag, Gerard Espinosa, Mathilde Leclercq, Gabriele Simonini, Mathieu Vautier, Patrice Cacoub & David Saadoun. (2023) Tocilizumab in Behçet Disease: A Multicenter Study of 30 Patients. The Journal of Rheumatology 50:7, pages 916-923.
Crossref
Sabine Karam, Mohamad Haidous, Virginie Royal & Nelson Leung. (2023) Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review. Kidney International 103:3, pages 473-484.
Crossref
Guzin Karatemiz, Sinem Nihal Esatoglu, Mert Gurcan, Yesim Ozguler, Sebahattin Yurdakul, Vedat Hamuryudan, Izzet Fresko, Melike Melikoglu, Emire Seyahi, Serdal Ugurlu, Huri Ozdogan, Hasan Yazici & Gulen Hatemi. (2023) Frequency of AA amyloidosis has decreased in Behçet’s syndrome: a retrospective study with long-term follow-up and a systematic review. Rheumatology 62:1, pages 9-18.
Crossref
Jordan Thorne, David Clark, Laurette Geldenhuys, Keigan More, Amanda Vinson & Karthik Tennankore. (2022) Serum Amyloid A Protein–Associated Kidney Disease: Presentation, Diagnosis, and Management. Kidney Medicine 4:8, pages 100504.
Crossref
D. Giannese, F. Ferro, D. Moriconi, A. G. Bonadio, E. Elefante, M. F. Egidi, A. Cupisti & C. Baldini. (2020) Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review. CEN Case Reports 10:1, pages 23-29.
Crossref
Mitsuhiro Akiyama, Yuko Kaneko & Tsutomu Takeuchi. (2020) Effectiveness of tocilizumab in Behcet's disease: A systematic literature review. Seminars in Arthritis and Rheumatism 50:4, pages 797-804.
Crossref
Omer Karadag & Ertugrul Cagri Bolek. (2020) Management of Behcet’s syndrome. Rheumatology 59:Supplement_3, pages iii108-iii117.
Crossref
Eiji Suzuki, Takashi Kanno, Ryoma Oda, Ryoichiro Kobashi, Hidemichi Imamura, Hajime Odajima, Makiko Yashiro Furuya & Kiyoshi Migita. (2020) Effectiveness of tocilizumab for Behcet disease complicated by amyloidosis in the intestinal tract. Medicine: Case Reports and Study Protocols 1:2, pages e0022.
Crossref
Ahmet Ilbay, Abdulsamet Erden, Alper Sari, Berkan Armagan, Burak Yasin Aktas, Ertugrul Cagri Bolek, Umut Kalyoncu & Omer Karadag. (2019) Successful Treatment of Amyloid A–Type Amyloidosis Due to Behçet Disease With Tocilizumab. JCR: Journal of Clinical Rheumatology 25:4, pages e43-e45.
Crossref
Jurgen Sota, Donato Rigante, Giuseppe Lopalco, Bruno Frediani, Rossella Franceschini, Mauro Galeazzi, Florenzo Iannone, Gian Marco Tosi, Claudia Fabiani & Luca Cantarini. (2017) Biological therapies for the treatment of Behçet’s disease-related uveitis beyond TNF-alpha blockade: a narrative review. Rheumatology International 38:1, pages 25-35.
Crossref
Serdal Ugurlu, Aysa Hacioglu, Yasaman Adibnia, Vedat Hamuryudan & Huri Ozdogan. (2017) Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever. Orphanet Journal of Rare Diseases 12:1.
Crossref
Alban Deroux, Chistophe Chiquet & Laurence Bouillet. (2016) Tocilizumab in severe and refractory Behcet’s disease: Four cases and literature review. Seminars in Arthritis and Rheumatism 45:6, pages 733-737.
Crossref
Shunichi Fujita, Nami Kosaka, Takafumi Mito, Hiroaki Hayashi & Yoshitaka Morita. (2015) Development of aseptic subcutaneous abscess after tocilizumab therapy in a patient with SAPHO syndrome complicated by amyloid A amyloidosis. International Journal of Rheumatic Diseases 18:4, pages 476-479.
Crossref
Julen Cadiñanos, Ramón Costa, Davinia Trujillo & Diego Real de Asúa. (2015) Amiloidosis sistémica secundaria AA. Medicina Clínica 144:7, pages 324-330.
Crossref
Julen Cadiñanos, Ramón Costa, Davinia Trujillo & Diego Real de Asúa. (2015) Systemic secondary AA amyloidosis. Medicina Clínica (English Edition) 144:7, pages 324-330.
Crossref
S. Yilmaz, M. Cinar, I. Simsek, H. Erdem & S. Pay. (2014) Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever. Rheumatology 54:3, pages 564-565.
Crossref
Shunsuke Yamada, Akihiro Tsuchimoto, Yoshiki Kaizu, Masatomo Taniguchi, Kosuke Masutani, Hiroshi Tsukamoto, Hiroaki Ooboshi, Kazuhiko Tsuruya & Takanari Kitazono. (2014) Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis. CEN Case Reports 3:2, pages 237-243.
Crossref
Francesco Caso, Luisa Costa, Donato Rigante, Orso Maria Lucherini, Paolo Caso, Vittoria Bascherini, Bruno Frediani, Rolando Cimaz, Edoardo Marrani, Laura Nieves-Martín, Mariangela Atteno, Carmela G. L. Raffaele, Giusyda Tarantino, Mauro Galeazzi, Leonardo Punzi & Luca Cantarini. (2014) Biological Treatments in Behçet’s Disease: Beyond Anti-TNF Therapy. Mediators of Inflammation 2014, pages 1-14.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.